论文部分内容阅读
肾移植病人接受免疫抑制剂治疗增加了皮肤肿瘤发生的危险.本文报告523例肾移植病人,有7.5%患者发生恶性肿瘤,其中72%肿瘤原发于皮肤.与普通人群相比较,肾移植病人的皮肤癌发生率是普通人群的3.2倍;鳞状细胞癌的发生率是普通人群鳞状细胞癌发生率的18.4倍,基底细胞癌的发生率是将普通人群基底细胞癌发生率的1.4倍.鳞状细胞癌与基底细胞癌之比为2.3∶1;而普通人群鳞状细胞癌与基底细胞癌之比则为0.2∶1.肾移植病人与普通人群皮肤癌发病的部位没有明显差异.但是肾移植病人
Kidney transplant patients receiving immunosuppressive therapy increase the risk of skin tumors. This article reports 523 cases of kidney transplant patients, 7.5% of patients with malignant tumors, of which 72% of primary tumors in the skin. Compared with the general population, kidney transplant patients The incidence of skin cancer is 3.2 times that of the general population; the incidence of squamous cell carcinoma is 18.4 times that of the squamous cell carcinoma in the general population, and the incidence of basal cell carcinoma is 1.4 times the incidence of basal cell carcinoma in the general population. The ratio of squamous cell carcinoma to basal cell carcinoma was 2.3:1; the ratio of squamous cell carcinoma to basal cell carcinoma in the general population was 0.2:1. There was no significant difference in the incidence of skin cancer between kidney transplant patients and general population. However, kidney transplant patients